WWM
NVAX icon

Wolff Wiese Magana’s Novavax NVAX Stock Holding History

Wolff Wiese Magana’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$7 – 1019
2025
Q2 		$7 Hold
1
– – ﹤0.01% 981
2025
Q1 		$7 Buy
+1
New +$8 ﹤0.01% 991
2023
Q4 		– Sell
-12
Closed -$87 – 810
2023
Q3 		$87 Buy
+12
New +$96 ﹤0.01% 776
2022
Q3 		– Sell
-10
Closed -$1K – 932
2022
Q2 		$1K Hold
10
– – ﹤0.01% 798
2022
Q1 		$1K Hold
10
– – ﹤0.01% 779
2021
Q4 		$1K Hold
10
– – ﹤0.01% 773
2021
Q3 		$2K Sell
10
-100
-91% -$22K ﹤0.01% 728
2021
Q2 		$23K Hold
110
– – 0.02% 381
2021
Q1 		$20K Hold
110
– – 0.02% 394
2020
Q4 		$12K Buy
+110
New +$11.7K 0.01% 425

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolff Wiese Magana's NVAX Position: Q3 2025 in Review

Wolff Wiese Magana sold out of Novavax (NVAX) in Q3 2025, closing a stake of 1 share — an estimated $7 sold.

Wolff Wiese Magana first reported a position in NVAX in Q4 2020 and held it in 10 quarters. The position peaked at $23K in Q2 2021. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Wolff Wiese Magana reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 1 Novavax share in Q3 2025, an estimated $7.
  • Wolff Wiese Magana first reported a position in Novavax in Q4 2020 and held it in 10 quarters.
  • Wolff Wiese Magana's Novavax position peaked at $23K in Q2 2021.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.